Clinical Trials Directory

Trials / Sponsors / MoonLake Immunotherapeutics AG

MoonLake Immunotherapeutics AG

Industry · 10 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participan
Arthritis, Psoriatic
Phase 32025-11-13
Enrolling By InvitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participan
Hidradenitis Suppurativa
Phase 32025-06-27
CompletedAn Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration
Relative Bioequivalence
Phase 12025-06-05
RecruitingAn Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolesc
Hidradenitis Suppurativa
Phase 32024-12-30
RecruitingEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 32024-10-15
Active Not RecruitingEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Anti
Arthritis, Psoriatic
Phase 32024-10-15
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Partici
Hidradenitis Suppurativa
Phase 32024-05-15
Active Not RecruitingStudy to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participa
Hidradenitis Suppurativa
Phase 32024-05-14
CompletedEvaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 22022-12-13
CompletedEvaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativ
Hidradenitis Suppurativa
Phase 22022-04-25